PROGRAM PROFILE

Occupational Hazard: Disruptive Behavior in Patients

Author and Disclosure Information

 

References

Conclusion

Accurate reporting of DB events enables the development of strategies for multidisciplinary teams to work together to minimize hazards and to provide interventions that provide for the safe delivery of health care to all patients. Improving reporting ensures there is an accurate representation of how disruptive events impact care provided within a facility—and what types of variables may be associated with increased risk for these types of events.

Additionally, ensuring that reporting is maximized also provides the VHA with opportunities for DBCs to offer evidence-based risk assessment of violence and consultation to staff members who may benefit from improved competencies in working with patients who display DB. These potential improvements are consistent with the VHA I CARE values and will provide data that can inform recommendations for health care in other agencies/health care organizations.

Acknowledgments
This work was supported by the Center of Innovation on Disability and Rehabilitation Research (CINDRR) of the Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs.

Pages

Recommended Reading

Current State of Hepatitis C Care in the VA
Federal Practitioner
Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance Use Disorders (FULL)
Federal Practitioner
Cannabis use, potency linked to psychotic disorder risk
Federal Practitioner
FDA approves brexanolone for postpartum depression
Federal Practitioner
Patients with OCD/hoarding differ from those with OCD/nonhoarding
Federal Practitioner
BP control slowed brain damage in elderly hypertensives
Federal Practitioner
Atypical used in Parkinson’s lifts hallucinations, delusions in refractory schizophrenia
Federal Practitioner
Report calls for focus on ‘subpopulations’ to fight opioid epidemic
Federal Practitioner
Revering Furry Valor
Federal Practitioner
Brexanolone approval ‘marks an important milestone’
Federal Practitioner

Related Articles